With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
ECHO PITCH 2024
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
December 7, 2020 @ 8:30 am - December 8, 2020 @ 2:30 pm EST
Medicine by Design’s 5th Annual Symposium will bring together principal investigators and trainees from across the University of Toronto and its affiliated hospitals, members of our Scientific Advisory Board, representatives from our ecosystem partners across industry, the investment community, government and the not-for-profit sector, and international collaborators to advance our research toward impact.
The theme of this year’s virtual symposium is Better Science through Convergence. Through talks by invited speakers from across North America and Medicine by Design principal investigators, we will highlight how collaboration and convergence across research disciplines are accelerating regenerative medicine discoveries and translation. We will also hold a virtual poster session featuring the research of select trainees working on Medicine by Design-funded projects.
Please visit, https://mbd.utoronto.ca/event/5th-annual-medicine-by-design-symposium/, for more info on registration and program.